Macugen® the first anti-VEGF inhibitor to be approved by the FDA for the treatment of wet age-related macular degeneration.
Subscribe to:
Post Comments (Atom)
Macugen® the first anti-VEGF inhibitor to be approved by the FDA for the treatment of wet age-related macular degeneration.
No comments:
Post a Comment